Veterinary Medicine Information website

MILBEVET 12.5 MG/125 MG CHEWABLE TABLETS FOR DOGS

Authorised
  • Milbemycin oxime
  • Praziquantel

Product identification

Medicine name:
MILBEVET 12.5 MG/125 MG CHEWABLE TABLETS FOR DOGS
Active substance:
  • Milbemycin oxime
  • Praziquantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    12.50
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    125.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • Box of 1 Aluminium/aluminium blisters (OPA/Al/PVC/Al/Heat-Seal coating) of 2 tablets
  • Box of 24 Aluminium/aluminium blisters (OPA/Al/PVC/Al/Heat-Seal coating) of 4 tablets
  • Box of 12 aluminium strips (polyester/Al/PE) of 4 tablets
  • Box of 12 Aluminium/aluminium blisters (OPA/Al/PVC/Al/Heat-Seal coating) of 4 tablets
  • Box of 1 aluminium strips (polyester/Al/PE) of 4 tablets
  • Box of 1 Aluminium/aluminium blisters (OPA/Al/PVC/Al/Heat-Seal coating) of 4 tablets
  • Box of 1 aluminium strips (polyester/Al/PE) of 2 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 127659
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0434/003
Concerned member states:
  • Netherlands
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 7/02/2025
Updated on: 14/03/2026
Download
Dutch (PDF)
Published on: 6/04/2022